Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS20AT04 in Lupus Nephritis or Lupus Cytopenia
NCT04835883Phase 2Recruiting
- Sponsor
- Hanyang University
- Start
- Sep 2019
- Primary completion
- Nov 2021
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CS20AT04 in systemic lupus erythematosus (SLE), sponsored by Hanyang University. Started Sep 2019; status: recruiting.
02
Drugs
CS20AT04
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04835883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04835883.